Stay updated on Inhaled Imatinib for PAH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.

Latest updates to the Inhaled Imatinib for PAH Clinical Trial page
- Check3 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a small update to the page version and metadata. No study data or content changes are indicated.SummaryDifference0.0%

- Check10 days agoChange DetectedThe study record for NCT05036135 shows termination with a note that AV-101 inhaled imatinib did not prove efficacy at any dose; the termination statement is included in the Study Details with the last update posted on 2024-08-23.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision/version indicator has been updated from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check46 days agoChange DetectedUI/layout updates and metadata refresh were observed; no core study details appear to have changed.SummaryDifference0.0%

- Check53 days agoChange DetectedThe core study details appear unchanged; only visual/layout differences are visible.SummaryDifference0.0%

- Check60 days agoChange DetectedAdded Naples, Italy, 80131 as a study location and removed Napoli, Italy, 80131. Page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Inhaled Imatinib for PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.